Status:
UNKNOWN
Improving Primary Spontaneous Pneumothorax (PSP) Treatment Techniques in VATS
Lead Sponsor:
Beijing Haidian Hospital
Collaborating Sponsors:
Peking University People's Hospital
Conditions:
Pneumothorax
Pleurodesis
Eligibility:
All Genders
10-45 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to: 1. Evaluate the validity of using abnormal characteristics of the pneumothorax line, as evaluated from chest X-ray film, as the operative indications for video-assist...
Eligibility Criteria
Inclusion
- patients in whom obvious bullous forms are seen in PSP pneumothorax lines, or whose pneumothorax lines are rough and interrupted with or without thoracentesis, thoracic close drainage
- patients whose lung compression exceeded 30% for the first incidence of pneumothorax
- patients between the ages of 14 and 40, with normal vital signs (body temperature, breathing, blood pressure, pulse) and normal results on routine examination (routine blood test, liver and kidney functions)
- no language barrier, such as surdimutism, aphasia
- patients who voluntarily joined the group and signed the informed consent after reviewing the substance, significance and risks of this experiment
Exclusion
- patients who refuse VATS operation
- patients who refuse the follow-up
- patients with secondary spontaneous pneumothorax including that caused by emphysema, COPD, asthma, pulmonary lymphangiomyomatosis, thoracic injury and other diseases
- patients with mental illness, low IQ, or inability to understand the informed consent
- substance abusers
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2013
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT01463553
Start Date
July 1 2011
End Date
November 1 2013
Last Update
November 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Haidian Hospital
Beijing, Beijing Municipality, China, 100080